Man Group
BLUE

Man Group’s bluebird bio BLUE Stock Holding History

Man Group’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,545
Closed -$150K – 2075
2022
Q1 		$150K Buy
+1,545
New +$204K ﹤0.01% 1998
2021
Q2 		– Sell
-1,615
Closed -$631K – 1959
2021
Q1 		$631K Sell
1,615
-8,682
-84% -$4.28M ﹤0.01% 1417
2020
Q4 		$5.77M Sell
10,297
-3,094
-23% -$1.96M 0.03% 733
2020
Q3 		$9.36M Buy
13,391
+7,015
+110% +$5.47M 0.04% 499
2020
Q2 		$5.04M Buy
+6,376
New +$4.81M 0.03% 656
2019
Q2 		– Sell
-593
Closed -$1.21M – 1886
2019
Q1 		$1.21M Buy
+593
New +$1.04M ﹤0.01% 1527
2018
Q4 		– Sell
-472
Closed -$891K – 1927
2018
Q3 		$891K Buy
472
+231
+96% +$477K ﹤0.01% 1710
2018
Q2 		$489K Sell
241
-2,372
-91% -$5.41M ﹤0.01% 1816
2018
Q1 		$5.78M Buy
+2,613
New +$6.65M 0.03% 768

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Man Group's BLUE Position: Q2 2022 in Review

Man Group sold out of bluebird bio (BLUE) in Q2 2022, closing a stake of 1,545 shares — an estimated $150K sold.

Man Group first reported a position in BLUE in Q1 2018 and held it in 9 quarters. The position peaked at $9.36M in Q3 2020. 151 funds tracked by Wall St. Rank hold BLUE as of Q2 2022.

  • Man Group reported no remaining bluebird bio position as of Q2 2022 after selling out during the quarter.
  • Man Group sold 1,545 bluebird bio shares in Q2 2022, an estimated $150K.
  • Man Group first reported a position in bluebird bio in Q1 2018 and held it in 9 quarters.
  • Man Group's bluebird bio position peaked at $9.36M in Q3 2020.
  • 151 funds tracked by Wall St. Rank held bluebird bio as of Q2 2022.

Based on Man Group's 13F filing for Q2 2022, filed 15 Aug 2022.